Literature DB >> 821139

Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

W F Riesen, F Skvaril, D G Braun.   

Abstract

The level of antibodies specific for the two serologically distinct polysaccharides of group A and group A-variant streptococci was investigated in human sera by a modified Farr technique. Whereas there was an obvious relationship between the anti-streptolysin O titer and the level of group-A-specific antibodies, suggesting a recent streptococcal infection with group A streptococci, this correlation was not apparent for the level of group A-variant antibodies. There is evidence suggesting that children have significantly lower group A polysaccharide antibody levels than adults; this is not true of their group A-variant antibody levels. There was an apparent restriction of groups A- and A-variant-specific antibodies to the kappa light-chain type and IgG2 heavy-chain subclass. Whereas only one serum contained group A-specific antibodies also associated with IgG3 heavy chains, nine sera contained anti-group A-variant-specific antibodies with both IgG2 and IgG3 heavy chains. No anti-polysaccharide activity was detected in the IgM and IgA class of serum antibodies. Anti-group A and anti-group A-variant antibodies of human sera are restricted with respect to the number of clonotypes that are shown by isoelectric focusing. The most heterogeneous sera contained roughly ten clonotypes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821139     DOI: 10.1111/j.1365-3083.1976.tb00292.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  60 in total

1.  Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues.

Authors:  P B Yu; W Parker; M L Everett; I J Fox; J L Platt
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Authors:  Xian Yu; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Katherine Sosa; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

3.  IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4.

Authors:  F N Boctor; J B Peter
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

4.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

5.  Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency.

Authors:  D M Roberton; J Björkander; J Henrichsen; T Söderström; L A Hanson
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  Characterization of the subclasses and light chain types of IgG antibodies to rubella.

Authors:  F Skvaril; U Schilt
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Susceptibility to infections in children with selective IgA- and IgA-IgG subclass deficiency.

Authors:  A Morell; E Muehlheim; U Schaad; F Skvaril; E Rossi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

8.  The IgG2a antibody response to thyroglobulin is linked to the Igh locus in mouse.

Authors:  R C Kuppers; L D Epstein; I M Outschoorn; N R Rose
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass.

Authors:  Stephan von Gunten; David F Smith; Richard D Cummings; Stefan Riedel; Sylvia Miescher; Alexander Schaub; Robert G Hamilton; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-05-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.